Samad Sayed, Rishikesh Kumar, Martin Zarba, Amina Taleb, Simon Mairs, Naveen S. Basappa, Michael Paul Kolinsky, Meghan Elizabeth Mahoney, Vishal Navani, Tina Cheng, Richard M. Lee-Ying, Safiya Karim, Scott A. North, Daniel Yick Chin Heng, Steven M. Yip, Nimira S. Alimohamed. "Dose modifications, toxicity, and survival with enfortumab vedotin plus pembrolizumab (EVP) in advanced urothelial carcinoma (aUC): Real-world experience in Alberta, Canada.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.188